BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 14584081)

  • 1. The analysis of immunophenotype of gastrin-producing tumors of the pancreas and gastrointestinal tract.
    Gurevich L; Kazantseva I; Isakov VA; Korsakova N; Egorov A; Kubishkin V; Bulgakov G
    Cancer; 2003 Nov; 98(9):1967-76. PubMed ID: 14584081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of gastrinomas by immunohistochemistry and in situ hybridization histochemistry.
    Perkins PL; McLeod MK; Jin L; Fukuuchi A; Cho KJ; Thompson NW; Lloyd RV
    Diagn Mol Pathol; 1992 Sep; 1(3):155-64. PubMed ID: 1285276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome.
    Pipeleers-Marichal M; Somers G; Willems G; Foulis A; Imrie C; Bishop AE; Polak JM; Häcki WH; Stamm B; Heitz PU
    N Engl J Med; 1990 Mar; 322(11):723-7. PubMed ID: 1968616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different splice variants of CD44 are expressed in gastrinomas but not in other subtypes of endocrine pancreatic tumors.
    Chaudhry A; Gobl A; Eriksson B; Skogseid B; Oberg K
    Cancer Res; 1994 Feb; 54(4):981-6. PubMed ID: 7508823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sonic hedgehog and pancreatic-duodenal homeobox 1 expression distinguish between duodenal and pancreatic gastrinomas.
    Fendrich V; Ramerth R; Waldmann J; Maschuw K; Langer P; Bartsch DK; Slater EP; Ramaswamy A; Rothmund M
    Endocr Relat Cancer; 2009 Jun; 16(2):613-22. PubMed ID: 19240184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The pathology of insulinoma and gastrinoma. The location, size, multicentricity, association with multiple endocrine type-I neoplasms and malignancy].
    Donow C; Pipeleers-Marichal M; Stamm B; Heitz PU; Klöppel G
    Dtsch Med Wochenschr; 1990 Sep; 115(37):1386-91. PubMed ID: 1976084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
    Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB
    J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent gastrinoma and somatostatinoma in a 10-year-old Portuguese water dog.
    Hoenerhoff M; Kiupel M
    J Comp Pathol; 2004 May; 130(4):313-8. PubMed ID: 15053935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of insulin-like growth factor I and/or its receptor in gastrinomas is associated with low curability, increased growth, and development of metastases.
    Furukawa M; Raffeld M; Mateo C; Sakamoto A; Moody TW; Ito T; Venzon DJ; Serrano J; Jensen RT
    Clin Cancer Res; 2005 May; 11(9):3233-42. PubMed ID: 15867218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas.
    Goebel SU; Serrano J; Yu F; Gibril F; Venzon DJ; Jensen RT
    Cancer; 1999 Apr; 85(7):1470-83. PubMed ID: 10193936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary lymph node gastrinoma or occult duodenal microgastrinoma with lymph node metastases in a MEN1 patient: the need for a systematic search for the primary tumor.
    Anlauf M; Enosawa T; Henopp T; Schmitt A; Gimm O; Brauckhoff M; Dralle H; Musil A; Hauptmann S; Perren A; Klöppel G
    Am J Surg Pathol; 2008 Jul; 32(7):1101-5. PubMed ID: 18520436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of the ability of serial measurements of serum chromogranin A and gastrin to detect changes in tumor burden in patients with gastrinomas.
    Abou-Saif A; Gibril F; Ojeaburu JV; Bashir S; Entsuah LK; Asgharian B; Jensen RT
    Cancer; 2003 Jul; 98(2):249-61. PubMed ID: 12872342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrinomas associated with MEN-1 syndrome: new insights for the diagnosis and management in a series of 11 patients.
    Nikou GC; Toubanakis C; Nikolaou P; Giannatou E; Marinou K; Safioleas M; Karamanolis D
    Hepatogastroenterology; 2005; 52(66):1668-76. PubMed ID: 16334754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies into gastrinomas and combined carcinomatous carcinoid tumors. Optical light- and electron microscopy and immunohistochemistry.
    Lászik Z; Krenács T; Baltás B; Pap A; Karácsony S
    Zentralbl Allg Pathol; 1989; 135(7):657-65. PubMed ID: 2480034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endocrine tumors of the pancreas: immunohistochemical and clinical correlation].
    Berney C; Kurt AM; Kapanci Y
    Schweiz Med Wochenschr; 1994 Feb; 124(5):179-85. PubMed ID: 8128199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-chromosome loss of heterozygosity frequently occurs in gastrinomas and is correlated with aggressive tumor growth.
    Chen YJ; Vortmeyer A; Zhuang Z; Gibril F; Jensen RT
    Cancer; 2004 Apr; 100(7):1379-87. PubMed ID: 15042671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syndromic versus non-syndromic sporadic gastrin-producing neuroendocrine tumors of the duodenum: comparison of pathological features and biological behavior.
    Rosentraeger MJ; Garbrecht N; Anlauf M; Raffel A; Knoefel WT; Wiedenmann B; Klöppel G
    Virchows Arch; 2016 Mar; 468(3):277-87. PubMed ID: 26649731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice. Heterogeneity of hormone expression.
    Rindi G; Grant SG; Yiangou Y; Ghatei MA; Bloom SR; Bautch VL; Solcia E; Polak JM
    Am J Pathol; 1990 Jun; 136(6):1349-63. PubMed ID: 2162628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features.
    Anlauf M; Garbrecht N; Henopp T; Schmitt A; Schlenger R; Raffel A; Krausch M; Gimm O; Eisenberger CF; Knoefel WT; Dralle H; Komminoth P; Heitz PU; Perren A; Klöppel G
    World J Gastroenterol; 2006 Sep; 12(34):5440-6. PubMed ID: 17006979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serine protease inhibitor 8 is a novel immunohistochemical marker for neuroendocrine tumors of the pancreas.
    de Koning PJ; Bovenschen N; Broekhuizen R; Lips CJ; Kummer JA
    Pancreas; 2009 May; 38(4):461-7. PubMed ID: 19188865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.